Based on Ghosh et al. (2023), which term matches each description: a major pilus protein, antibiotic resistance, a drug target, extracellular polymeric substances (EPS), and quorum sensing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Matching Terms with Descriptions Based on Ghosh et al. (2023)

Based on the Ghosh et al. (2023) paper published in the International Journal of Nanomedicine, the correct matches are:

Term-Description Matches

1. Quorum Sensing → The signaling mechanism that allows bacteria to sense and respond to their population density, playing a key role in biofilm formation and virulence.

  • Quorum sensing is explicitly described as a cell density-dependent signaling system that regulates biofilm formation, virulence factor expression, and bacterial communication 1, 2, 3, 4
  • This mechanism coordinates gene expression and enables bacteria to function as multicellular communities within biofilms

2. PilA Protein → A major protein involved in the formation of pili, which are critical for bacterial adhesion to surfaces and biofilm initiation.

  • Pili are bacterial cell filamentous appendages that act as adhesins, promoting attachment to abiotic surfaces 5
  • These structures are essential for initial bacterial colonization and biofilm establishment 6

3. Extracellular Polymeric Substances (EPS) → A complex matrix of sugars, proteins, and nucleic acids produced by bacteria in a biofilm that provides structural integrity and protects the bacteria from external threats.

  • EPS is composed of extracellular DNA, lipids, proteins, and polysaccharides that form the biofilm matrix 5
  • This matrix stabilizes and strengthens biofilm structure, enables nutrient retention, facilitates gene transfer, and protects bacteria from antimicrobial agents 7

4. Antibiotic Resistance → The ability of bacteria to survive and proliferate despite the presence of antimicrobial agents, often enhanced by biofilm formation.

  • Bacterial colonies in biofilms can resist multiple doses of antibacterial compounds due to the protective EPS matrix and altered bacterial physiology 5
  • Polysaccharide intracellular adhesin-positive bacterial species demonstrate greater antibiotic resistance compared to negative strains 5

5. Drug Target → A specific molecule or structure within a pathogen that can be targeted by drugs or other therapeutic agents to disrupt its function or prevent infection.

  • Virulence factors, adhesins, and quorum sensing components represent specific molecular targets for therapeutic intervention 8
  • These include bacterial surface proteins, signaling molecules, and enzymes involved in biofilm formation and pathogenesis 1, 9

Key Clinical Context

The Ghosh et al. (2023) paper emphasizes that biofilm-associated infections on biomaterials and medical devices represent a major clinical challenge because bacteria within biofilms exhibit enhanced resistance to both antibiotics and host immune defenses 5. Understanding these fundamental components—from initial adhesion via pili to mature biofilm formation with EPS protection and quorum sensing coordination—is essential for developing effective anti-biofilm and anti-virulence strategies 10, 3, 4.

References

Research

Relevance of microbial extracellular polymeric substances (EPSs)--Part I: Structural and ecological aspects.

Water science and technology : a journal of the International Association on Water Pollution Research, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.